title: Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy.
authors.affiliation: Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, CA 92121, USA.
authors.forename: Denis
authors.initials: D
authors.lastname: Drygin
authors.forename: Mustapha
authors.initials: M
authors.lastname: Haddach
authors.forename: Fabrice
authors.initials: F
authors.lastname: Pierre
authors.forename: David M
authors.initials: DM
authors.lastname: Ryckman
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D011487:Protein Conformation; D051573:Proto-Oncogene Proteins c-pim-1 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000502:physiology; D015398:Signal Transduction
chemical_list: D000970:Antineoplastic Agents; D007527:Isoenzymes; D051573:Proto-Oncogene Proteins c-pim-1; C406031:proto-oncogene proteins pim